Scientific Advisory Board
The Lymphoma Research Foundation’s Scientific Advisory Board (SAB), comprised of 45 world-renowned lymphoma experts, seeks out the most innovative and promising lymphoma research projects for support. Members of the Foundation’s SAB are leaders in blood cancer research, with outstanding experience and accomplishments in both lymphoma-specific research and clinical care. They guide the planning of LRF’s research program, selecting and monitoring grant recipients.
ANDREW D. ZELENETZ, MD, PhD
Chair
Memorial Sloan Kettering Cancer Center, New York
Andrew D. Zelenetz, MD, PhD, is the Medical Director of Quality Informatics at Memorial Sloan Kettering Cancer Center in New York. Prior to that, he had held the positions of Vice Chair, Medical Informatics from January 2013 to May 2016 and Chief, Lymphoma Service in the Division of Hematology/Oncology at MSKCC from 1994-December 2012. He is also a Professor of Medicine at Weill Cornell Medical College. Dr. Zelenetz was elected Chair-Elect of the SAB in 2017, assuming the Chair in 2019.
He has helped develop several agents now approved to treat lymphoma — including 131I-tosituomab/tositumomab, bortezomib, and pralatrexate — and through clinical studies he is evaluating the benefits of novel combinations of agents. Dr. Zelenetz has also published more than 100 papers on lymphoma research in journals such as Blood, Journal of Clinical Oncology and Clinical Cancer Research.
SONALI M. SMITH MD
Chair-Elect
The University of Chicago
RANJANA ADVANI, MD
Stanford University School of Medicine
ASH A. ALIZADEH, MD, PhD
Stanford University School of Medicine
STEPHEN ANSELL, MD, PhD
Mayo Clinic, Rochester
NANCY BARTLETT, MD
Washington University Medical School
KRISTIE A. BLUM, MD
Winship Cancer Institute of Emory University
CATHERINE BOLLARD, MD, MBChB
George Washington University
Children’s National Medical Center
ETHEL CESARMAN, MD, PhD
NewYork-Presbyterian Hospital
Weill Cornell Medicine
BRUCE D. CHESON, MD, FACP, FAAAS, FASCO
Past Chair, 2010-2012
Georgetown University Hospital
Lombardi Comprehensive Cancer Center
MORTON COLEMAN, MD
Chair, Medical Affiliates Board
NewYork-Presbyterian Hospital
Weill Cornell Medicine
SANDEEP DAVE, MD, MS
Duke University
KIERON M. DUNLEAVY, MD
George Washington University
GW Cancer Center
KOJO S.J. ELENITOBA-JOHNSON, MD
University of Pennsylvania
Perelman School of Medicine
ANDREW M. EVENS, DO, MSc, FACP
Rutgers Cancer Institute of New Jersey
CHRISTOPHER R. FLOWERS, MD, MS
Winship Cancer Institute of Emory University
JONATHAN W. FRIEDBERG, MD, MMSc
University of Rochester
James P. Wilmot Cancer Institute
LEO I. GORDON, MD, FACP
Past Chair, 2015-2017
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
THOMAS M. HABERMANN, MD
Immediate Past Chair, 2017-2019
Mayo Clinic, Rochester
STEVEN M. HORWITZ
Memorial Sloan Kettering Cancer Center
ERIC D. HSI, MD
Cleveland Clinic
BRAD S. KAHL, MD
Washington University School of Medicine
KARA KELLY, MD
Roswell Park Comprehensive Cancer Center
University at Buffalo Jacobs School of Medicine
ANN S. LACASCE, MD
Harvard Medical School
Dana-Farber Cancer Institute
JOHN P. LEONARD, MD
Past Chair, 2012-2015
NewYork-Presbyterian Hospital
Weill Cornell Medicine
BRIAN K. LINK, MD
University of Iowa
IZIDORE S. LOSSOS, MD
University of Miami Health System
Sylvester Comprehensive Cancer Center
PETER MARTIN, MD
Weill Cornell Medicine
ARI MELNICK, MD
NewYork-Presbyterian Hospital
Weill Cornell Medicine
LINDSAY M. MORTON, PhD
National Cancer Institute
OWEN O’CONNOR, MD, PhD
Columbia University Medical Center
LAURA PASQUALUCCI, MD
Columbia University
H. Irving Comprehensive Cancer Center
BARBARA PRO, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
KANTI R. RAI, MD, BS
Hofstra Northwell School of Medicine
KERRY SAVAGE, MD
British Columbia Cancer Agency
LAURIE SEHN, MD, MPH
British Columbia Cancer Agency
MARGARET SHIPP, MD
Harvard Medical School
Dana-Farber Cancer Institute
EDUARDO M. SOTOMAYOR, MD
George Washington University
GW Cancer Center
CHRISTIAN STEIDL, MD
British Columbia Cancer Agency
JOHN M. TIMMERMAN
UCLA Jonsson Comprehensive Cancer Center
SVEN de VOS, MD, PhD
UCLA Jonsson Comprehensive Cancer Center
DAVID WEINSTOCK, MD
Harvard Medical School
Dana-Farber Cancer Institute
HANS-GUIDO WENDEL, MD
Memorial Sloan Kettering Cancer Center
MICHAEL E. WILLIAMS, MD, ScM
University of Virginia Cancer Center
Members Emeritus
JOSEPH R. BERTINO, MD
Founding Chair
Rutgers Robert Wood Johnson Medical School
Rutgers Cancer Institute of New Jersey
